Autologous dendritic cell vaccine loaded with autologous tumor lysate/homogenate
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for Autologous dendritic cell vaccine loaded with autologous tumor lysate/homogenate, covering 2025-01-09 to 2025-01-09. Get the full timeline:
Most recent: Clinical Trial Update: Vaccination With Autologous Dendritic Cells Loaded With Autologous Tumor Lysate or Homogenate Combined With Immunomodulating Radiotherapy and/or Preleukapheresis IFN-alfa in Patients With Metastatic Melanoma: a Randomized "Proof-of-principle" Phase II Study [Phase 2]